- LATIN AMERICA: Mexico, Costa Rica, Panama, Guatemala, Colombia, Chile, Peru, Argentina and Brazil
- EUROPE: Poland, Germany, Italy, Netherlands, Portugal
- MIDDLE EAST: Israel, Turkey, Egypt, United Arab Emirates, Lebanon, Cyprus
- ASIA: Korea, China, Hong Kong, Taiwan, Japan, Singapore, Thailand, Malaysia
Forward Looking Statements This news release includes certain forward-looking statements that are based upon the current expectations of management. Forward-looking statements involve risks and uncertainties associated with the business of Avivagen Inc. and the environment in which the business operates. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions "aim", "anticipate", "appear", "believe", "consider", "could", "estimate", "expect", "if", "intend", "goal", "hope", "likely", "may", "plan", "possibly", "potentially", "pursue", "seem", "should", "whether", "will", "would" and similar expressions. Statements about the future of the distribution relationship between Avivagen Inc. and PACC Pets and about the Global Pet Expo set out in this news release are forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. For instance, the distribution relationship with PACC Pets may not have the expected outcomes, may not be successful or may not expand as anticipated. Except as required by law, Avivagen assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. For more information: Avivagen Inc.Drew BasekDirector of Investor Relations100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6 Phone: 416-540-0733E-mail: email@example.com Kym AnthonyChairman & Interim CEO100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6 Head Office Phone: 613-949-8164Website: www.avivagen.com Copyright © 2018 Avivagen Inc. OxC-beta™ is a trademark of Avivagen Inc.